Steven Pittler, Ph.D., professor in the Department of Vision Sciences in the UAB School of Optometry, has received a four-year, $1.4 million National Institutes of Health National Eye Institute grant.
This work will focus on a protein that is unique to the eye and is required for sight. When the gene that encodes this protein is defective, it leads to the ocular disorder retinitis pigmentosa, a progressive hereditary form of blindness.
Pittler, who is also director of the Vision Science Research Center, will study the function of the protein to devise treatments for the disease. The grant is titled “Analysis of retina rod photoreceptor GARP and cGMP-gated channel.”
“This application seeks to identify fundamental properties of the genes’ encoded proteins that will provide essential information needed to develop a treatment, as there is no established treatment for this disease, which affects a significant portion of the United States and world populations,” Pittler said.
White House strategist to lead UAB’s Personalized Medicine InstituteMatt Might, Ph.D., a strategic leader in the White House Precision Medicine Initiative, has been named the inaugural director of the Hugh Kaul Personalized Medicine Institute at UAB.posted today 124 viewsUAB developing new peptide to combat a disorder that causes heart attacks at early ageSome people inherit a condition that elevates their cholesterol to an excessive degree, and no amount of diet or exercise can bring the numbers down. UAB researchers are developing and testing a new peptide that may lead to better treatment options.posted yesterday 1248 viewsArea middle schoolers to learn about STEM at UABThe event will be offered over two days in February, and will also include a parent/educator workshop this year.posted 5 days ago 322 viewsUAB to bring proton therapy for advanced cancer treatment to BirminghamUAB will bring proton therapy, one of the most technically advanced forms of cancer-killing radiation, to Alabama with the new Proton Therapy Center.posted 6 days ago 6331 viewsUsing protons to fight cancer: the science behind the UAB Proton CenterA 90-ton machine called a cyclotron will accelerate protons to very high speeds to impact human tumors.posted 6 days ago 2133 viewsGARP2 accelerates retinal degeneration in a mouse modelThe function and structure of protein GARP2 in rod cells of the retina is still not clear, but researchers have shown that GARP2 accelerates retinal degeneration in mice, and have made an important step toward creating a standardized nomenclature between mice and humans for a measurement of retinal degeneration.posted 7 days ago 792 viewsDothan man sees improvement in quality of life after LVAD surgeryJames Ward could not walk from his office to his car without having trouble breathing until a life-changing heart pump gave him hope.posted 8 days ago 7210 viewsDrivers can now charge electric vehicles on campus at UABDrivers of electric vehicles can now charge their cars at electronic vehicle service equipment ports on UAB’s campus.posted 9 days ago 833 viewsPeruvian native to lead top global tropical medicine training center at UABUAB names new leadership for Gorgas Center for Geographic Medicine.posted 9 days ago 1051 views7-year-old Suki Bateh inspires UAB and Children’s to create Sarah Katherine Bateh Endowed Professorship in Rett SyndromeThe Suki Foundation, Children’s of Alabama and UAB have established an endowed professorship in Rett syndrome.posted 12 days ago 10698 viewsUAB pulmonary investigators receive major NIH research grantsThree UAB investigators have received innovative research grants for lung diseases from the National Institutes of Health.posted 12 days ago 2490 viewsUAB first in Alabama to implement new FDA-approved PFO occluderMassoud Leesar, M.D., performed the first procedure Jan. 25, 2017, and that is good news for people who suffer strokes as a result of patent foramen ovale, or PFO.posted 13 days ago 890 viewsA “release and kill” strategy may aid treatment of tuberculosisTuberculosis kills 1.8 million people a year, and 10 million more are infected. Development of host-cell directed therapies that could restore cellular function during M. tuberculosis infection, such as a “release and kill” strategy, could shorten drug treatment of TB patients.posted 14 days ago 1412 viewsTwo global health case competitions to be hosted by UAB Sparkman Center for Global HealthUAB Sparkman Center for Global Health hosts global health case competitions for UAB students and students from across the state. Multidisciplinary teams propose innovative recommendations to a global health issue.posted 16 days ago 1418 views2017 Darwin Day commemorates Charles Darwin’s birthday, showcases scientific research
Poster sessions and guest lecturers aim to celebrate Darwin’s legacy.
Standard therapy used in pediatric cardiac ICU challenged by study in NEJMUAB researchers looked at body cooling versus normal temperature control in pediatric patients who suffered cardiac arrest in the hospital to find that neither is more beneficial.posted 19 days ago 1094 viewsBrain plasticity: How adult-born neurons get wired-inIt appears that new cells compete to ‘win’ synapse connections away from old cells, which promotes network plasticity.posted 20 days ago 2552 viewsUAB study shows children and parents over-report leukemia medication adherenceResearch from UAB suggests that nearly half of children with the most common type of leukemia or their parents say they took more medications than they actually did.posted 20 days ago 1417 viewsJia Cui wins graduate travel award from the American Society for Biochemistry and Molecular BiologyThe award recognizes a significant paper by Cui in Cell Death and Differentiation.posted 23 days ago 1161 viewsNEJM lauds UAB study as one of the top neurology stories of 2016A UAB study confirming the efficacy of surgical removal of the thymus for patients with myasthenia gravis was cited as one of the top neurology stories of the year by the New England Journal of Medicine.posted 26 days ago 2968 views
- Event Date February 9